ALT
Altimmune Inc
Price:  
4.08 
USD
Volume:  
3,487,067.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Altimmune EV/EBITDA

-745.3%
Upside

As of 2025-07-20, the EV/EBITDA ratio of Altimmune Inc (ALT) is -2.88. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Altimmune's latest enterprise value is 281.82 mil USD. Altimmune's TTM EBITDA according to its financial statements is -97.96 mil USD. Dividing these 2 quantities gives us the above Altimmune EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 12.7x - 13.6x 13.2x
Forward P/E multiples 20.5x - 42.4x 31.4x
Fair Price (24.15) - (15.82) (26.33)
Upside -692.0% - -487.7% -745.3%
4.08 USD
Stock Price
(26.33) USD
Fair Price

Altimmune EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-18 -2.88
2025-07-17 -2.85
2025-07-16 -2.96
2025-07-15 -2.96
2025-07-14 -3.03
2025-07-11 -2.93
2025-07-10 -3.14
2025-07-09 -3.42
2025-07-08 -3.29
2025-07-07 -3.17
2025-07-03 -3.44
2025-07-02 -3.56
2025-07-01 -3.00
2025-06-30 -2.70
2025-06-27 -2.40
2025-06-26 -2.49
2025-06-25 -5.88
2025-06-24 -5.45
2025-06-23 -5.29
2025-06-20 -5.32
2025-06-18 -5.11
2025-06-17 -5.20
2025-06-16 -5.19
2025-06-13 -5.23
2025-06-12 -5.42
2025-06-11 -4.91
2025-06-10 -5.08
2025-06-09 -4.43
2025-06-06 -4.15
2025-06-05 -4.02
2025-06-04 -4.04
2025-06-03 -3.99
2025-06-02 -3.89
2025-05-30 -3.99
2025-05-29 -4.14
2025-05-28 -4.04
2025-05-27 -4.06
2025-05-23 -4.23
2025-05-22 -4.28
2025-05-21 -4.13
2025-05-20 -4.34
2025-05-19 -4.05
2025-05-16 -4.12
2025-05-15 -4.28
2025-05-14 -4.22
2025-05-13 -4.27
2025-05-12 -4.48
2025-05-09 -4.13
2025-05-08 -4.30
2025-05-07 -3.94